5% of animal-tested therapies reach human regulatory approval, per PLOS Biology study.

A study published in PLOS Biology reveals that only 5% of therapies tested on animals reach regulatory approval for human use. The analysis of translational biomedical research reviews shows a high drop-off rate before final approval, despite a 50% translation rate to human studies. Researchers argue that improved robustness and generalizability of experimental approaches could increase the chances of successful translation and final approval.

June 13, 2024
6 Articles

Further Reading